Atlas Trials

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma

Clinical trial NCT00740415 · COMPLETED

Trial details

NCT number
NCT00740415
Sponsor
French Innovative Leukemia Organisation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2007-06-01
Primary completion
2011-05-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.